Navigation Links
Martin Zdanowicz Selected to Lead the KGI School of Pharmacy and Health Sciences
Date:8/6/2019

Keck Graduate Institute (KGI) President Sheldon Schuster has announced Martin Zdanowicz as the Dean of the KGI School of Pharmacy and Health Sciences (SPHS).

“Dean Zdanowicz is highly regarded as an innovative leader who prioritizes student success and faculty development,” said KGI Board of Trustees Chairman Jim Widergren. “He is a great choice to build on the success of the KGI School of Pharmacy and Health Sciences.”

KGI President Sheldon Schuster added: “Dean Zdanowicz is a respected professional in the field of pharmacy, and his insightful approach to educating the next generation of pharmacists will have profound impact on KGI and the industry. He will move the school forward by creating new and innovative opportunities for our students."

Dr. Zdanowicz, who spent the past seven years in a leadership role at the University of Miami, started his new position at KGI on August 1.

“I am very much looking forward to working with the outstanding faculty, staff, and students at KGI,” Zdanowicz said. “Together I believe we can accomplish many great things.”

While in Miami, Dr. Zdanowicz served as the Associate Dean for Health Studies at the University of Miami School of Nursing and Health Studies, where he oversaw programs in public health, health science, and informatics.

Dr. Zdanowicz received a Bachelor of Science in Biology from NYU-Polytechnic, a Master of Arts in biology/physiology from SUNY Binghamton, and a Doctor of Philosophy in Pharmaceutical Sciences (Pharmacology) from St. John’s University.

While completing his doctorate, Dr. Zdanowicz spent 12 years working as a research scientist at North Shore University Hospital-Cornell Medical College in the area of endocrinology and metabolism. In 1996, he assumed a full-time faculty appointment with the Massachusetts College of Pharmacy & Health Sciences (MCPHS) and served as Chair of Pharmaceutical Sciences and Director of Graduate Studies.

After eight years at MCPHS, Dr. Zdanowicz moved to the South University School of Pharmacy in Savannah, GA, where he served as Chair of Pharmaceutical Sciences. He was promoted to full professor in 2008, with his teaching areas including pharmacology, pathophysiology, and pharmacogenomics. Dean Zdanowicz received the Trustee’s Award for teaching excellence and was voted pharmacy teacher of the year six times by students at two institutions. He also received the Teacher of the Year award in 2015 from the School of Nursing and Health Studies at the University of Miami.

His current research interests include pharmacogenomics, drug addiction, curriculum development, and active learning techniques. Dr. Zdanowicz holds membership in a number of professional societies. He has also published numerous peer-reviewed articles and four textbooks.

Dr. Zdanowicz assumes leadership of the KGI School of Pharmacy and Health Sciences, which started in 2014 with the Doctor of Pharmacy, a four-year program that graduated its first class in 2018. In August 2018, SPHS added two programs: the Master of Science in Human Genetics and Genetic Counseling (MSGC) and the Master of Science in Human Genetics and Genomic Data Analytics (MSGDA). The first MSGC and MSGDA cohorts will graduate in May 2020.

Read the full story at https://www.prweb.com/releases/martin_zdanowicz_selected_to_lead_the_kgi_school_of_pharmacy_and_health_sciences/prweb16485364.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Bait research focused on outsmarting destructive beetle
2. EMBO Gold Medal 2014 awarded to Sophie Martin
3. Five-Time World Champion Boxer Vinny Paz Shares Thoughts About Upcoming Movie, Bleed For This (Executive Produced by Martin Scorsese and Starring Miles Teller), Boxing, God and Whats Next
4. Five-Time World Champion Boxer Vinny Paz Shares Thoughts About Upcoming Movie, "Bleed For This" (Executive Produced by Martin Scorsese and Starring Miles Teller), Boxing, God and Whats Next
5. Robots Moving Robots: Lockheed Martin Conducts First Fully Autonomous Mission
6. Avanade Tracks Williams Martini Racing Pit Crew Biometrics To Boost Future F1 Performance
7. Fred Hutch evolutionary geneticist Harmit Malik selected as an HHMI investigator
8. Stepping up the Pace: 20th International AIDS Conference (AIDS 2014) theme selected
9. Projecis Cloud-based Collaboration Platform Selected by Spaulding Clinical to Manage Phase I Clinical Trial Projects and Timelines
10. Top 12 Pioneer Awards for seminal work in gene and cell therapy selected by blue ribbon panel
11. Elsevier selected publish official journal: Engineering in Agriculture, Environment & Food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... provides personalized, easy-to-understand, web-based genetic counseling, today announced that the company has expanded ... to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded ...
(Date:7/19/2019)... ... 2019 , ... VetStem Biopharma has long been a leader in ... result of a two-year research collaboration with Calidi Biotherapeutics, VetStem has signed a worldwide ... VetStem should be able to fast-track this cancer therapy for use in dogs ...
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... BETHESDA, Md. and ROANOKE, Va. (PRWEB) , ... ... ... virtual care optimized for microlearning engagement, and Carilion Clinic, a national leader in ... leveraging the latest in virtual care. , Mytonomy recently deployed its ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study ... stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying their ... mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. This ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms of ... demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen ... engineered T cell receptors known as “CARs”. The CAR enables the final product to ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... on Data Integrity on July 08-09, 2019 in Boston, MA. This peer recommended ... medical device organizations. , The training will kick off with a compendial treatment ...
Breaking Biology Technology: